How to Inject Peptides: Injection Sites, Technique & Safety (2026)

Most injectable peptides used outside a clinic are delivered with a small subcutaneous shot into fat tissue, using an insulin syringe and a handful of repeatable steps. The technique itself is not complicated, but the details that prevent infection, lumps, and dosing mistakes are where people get hurt. This guide walks through sites, angles, needle sizes, aseptic technique, and the honest safety picture, including why most research peptides are not FDA-approved for human use.

A Note Before Anything Else

Most peptides discussed in fitness and longevity circles, including BPC-157, TB-500, CJC-1295, and ipamorelin, are sold as "research chemicals" and are not approved by the FDA for human or veterinary use. A small number of peptide drugs are FDA-approved (for example, semaglutide and tirzepatide for specific conditions) and come with manufacturer instructions you should follow exactly. The injection mechanics below are general and educational. They are not a recommendation to self-administer any unapproved substance, and the legal and safety status of these compounds is a moving target. See our peptide legality guide and peptide therapy side effects and risks for context before going further.

Subcutaneous vs. Intramuscular: Which Route, and Why

Two routes cover almost all peptide injections people ask about.

Subcutaneous (SubQ or SC) places the dose into the layer of fat just under the skin. This is the default for the large majority of peptides. Absorption is slower and steadier, the shot is shallow, and the needle is tiny. Most people can do it themselves with minimal discomfort.

Intramuscular (IM) places the dose deeper, into muscle. It is used far less often for peptides, mostly when a specific protocol or a clinician calls for it. IM uses a longer, sometimes thicker needle and carries a higher chance of bleeding, soreness, and hitting a nerve or blood vessel if you do not know the landmarks.

For nearly everything in the consumer peptide world, subcutaneous is the route. Reaching for an IM injection without a clear clinical reason adds risk without a clear benefit.

There is also a third route some products use: intranasal sprays, which skip the needle entirely but absorb very differently and unpredictably. For the rest of this guide, assume we are talking about a subcutaneous shot unless stated otherwise.

Feature	Subcutaneous (SubQ)	Intramuscular (IM)
Target tissue	Fat under the skin	Muscle
Typical needle gauge	29–31G	22–25G
Typical needle length	5/16" to 1/2" (8–13 mm)	1" to 1.5" (25–38 mm)
Insertion angle	45° or 90° (skin pinch)	90°
Common sites	Abdomen, thigh, upper arm fat	Deltoid, glute, vastus lateralis
Pain / difficulty	Low, easy to self-administer	Higher, more technique-dependent
Use case for peptides	The default for most	Rare, only when specified

This guide focuses on subcutaneous technique because that is what the vast majority of peptide protocols call for.

Equipment You Need

Keep the kit simple. The standard subcutaneous setup is an insulin syringe with a built-in fine needle.

Insulin syringe, typically 0.3 mL (30 unit), 0.5 mL (50 unit), or 1.0 mL (100 unit), with a 29–31 gauge, 5/16" to 1/2" needle. The barrel is marked in insulin "units" (100 units = 1 mL), which is how most dosing math is described.
Alcohol prep pads (70% isopropyl) for both the vial top and your skin.
The reconstituted peptide vial. Lyophilized (freeze-dried) peptide must be mixed with bacteriostatic water first. That is its own process covered in our peptide reconstitution guide; do not skip it, because dosing accuracy starts there.
An FDA-cleared sharps container, or a heavy-duty puncture-resistant plastic container with a tight lid as a backup.

A higher gauge number means a thinner needle. A 31G needle is thinner and generally less painful than a 29G. For subcutaneous peptide work, thinner is usually fine because the fluid volume is small.

Some people use a slightly larger needle to draw from the vial, then swap to a fresh fine needle to inject, which keeps the injecting needle sharp. With insulin syringes the needle is fixed to the barrel, so most users simply draw and inject with the same fine needle and accept that the tip dulls slightly.

Injection Sites and Rotation

The best subcutaneous sites are areas with a decent layer of fat that you can pinch.

Abdomen. The most popular site. Use the area roughly two inches out from the navel, spreading out toward the sides and down toward the hips. Avoid the area within about one inch of the belly button. The abdomen has a large surface and is easy to reach.
Outer or front of the thigh. Good for self-injection; plenty of fat and easy to see.
Back of the upper arm. Works if you can pinch the fat, though it is harder to reach on yourself.
Love handles / flank. Some people use the fattier area above the hip.

Avoid any skin that is bruised, red, swollen, scarred, broken, tattooed over a reaction, or sitting right over a bone.

Why Rotation Matters

This is not a minor detail. Injecting the same spot over and over is the single most reliable way to create problems.

Move each injection at least one to two inches from the last one, and cycle through different areas. The reason comes straight from decades of insulin research. Repeated injections in one spot cause lipohypertrophy, rubbery fat lumps under the skin. These lumps are extremely common in people who do not rotate; in insulin-treated patients, reported prevalence ranges widely but runs into the majority in some studies. The lumps are not just cosmetic. They change how the drug absorbs, so dosing becomes unpredictable. A review in Frontiers in Endocrinology identified improper site rotation and needle reuse as the most common factors tied to lipohypertrophy, and noted that systematic rotation is the most studied way to prevent it (Gentile et al., 2018).

Practical rule: do not inject more than once or twice a month in any single spot. Keeping a simple rotation log or rotating in a grid pattern works well.

Step-by-Step Subcutaneous Technique

This sequence follows standard self-injection instructions for subcutaneous medication (MedlinePlus). Read it through before your first attempt.

Wash your hands thoroughly with soap and water and dry them.
Inspect the vial and solution. It should look clear (or as the protocol describes) with no cloudiness, floaters, or color change. If it looks off, do not use it.
Wipe the vial top with a fresh alcohol pad and let it dry.
Draw your dose. Pull air into the syringe equal to your dose, push it into the vial to avoid a vacuum, then invert and draw the correct number of units. Tap out air bubbles and push them back into the vial so your dose is accurate.
Pick and prep the site. Choose a spot that follows your rotation plan. Clean it with a new alcohol pad in a circular motion from the center outward, and let it air dry completely. Do not fan, blow on it, or touch it again. Letting alcohol dry both reduces stinging and lets the antiseptic work.
Pinch the skin into a fold to lift the fat away from muscle. This is especially important for lean people.
Insert the needle. Use a 90° angle if you can pinch about two inches of skin, or a 45° angle if you can only grab about an inch. The 45° angle on shorter needles helps keep the dose out of muscle.
Inject slowly and steadily. Push the plunger all the way down.
Remove the needle at the same angle you went in, then release the pinch. A brief press with clean gauze is fine; do not rub hard.
Dispose of the needle immediately in your sharps container.

Aspiration (pulling back on the plunger to check for blood) is not needed for subcutaneous injections and is no longer recommended for routine subQ shots. It matters more for certain IM injections.

Reading the Dose on an Insulin Syringe

Most people who run into trouble do not fumble the needle; they fumble the math. Insulin syringes are marked in units, and 100 units equals 1 mL. So if you reconstitute a 5 mg vial with 2 mL of bacteriostatic water, you have 2.5 mg per mL, which is 0.025 mg (25 mcg) per unit. A 250 mcg dose would then be 10 units on the syringe.

The takeaway: the number on the barrel only means a specific dose after you have done the reconstitution math. Write your concentration on a piece of tape on the vial so you are not redoing arithmetic at 6 a.m. A smaller-barrel syringe (0.3 mL / 30 unit) has more widely spaced markings and makes small doses easier to read accurately than a 1 mL syringe. The full mixing and dosing walk-through lives in our peptide reconstitution guide.

Common Beginner Mistakes

Injecting into a lump. It absorbs unevenly and hurts. Rotate.
Not letting alcohol dry. Wet alcohol stings going in and can carry into the puncture.
Pushing too fast. A slow, steady plunger press is more comfortable and leaks less.
Big air bubbles. A tiny bubble in subQ is not dangerous, but it throws off your dose. Tap them out before injecting.
Reusing a "still sharp" needle. It is never as sharp as it feels, and it is the wrong corner to cut.

Aseptic Technique and Infection Risk

Infection is the most common avoidable injury from self-injection, and the fixes are unglamorous: clean hands, clean site, clean vial top, and a needle that touches nothing before it touches you.

The injection site should be cleaned with an antiseptic swab and allowed to dry before the needle goes in. The World Health Organization's injection-safety toolkit stresses the basics: prepare a clean work area, never recap a used needle with two hands, and dispose of sharps at the point of use to avoid needlestick injuries (WHO Best Practices for Injections). The evidence on skin antisepsis is reviewed by Canada's CADTH, which found alcohol swabbing before injection is the standard low-cost practice for reducing surface microbes (CADTH skin preparation review).

Warning signs of an infected injection site include spreading redness, warmth, swelling, increasing pain, pus, or fever. An abscess (a walled-off pocket of pus) needs medical drainage; you cannot fix it at home. If you see these signs, stop injecting and get care.

Two more rules that prevent grief:

Never reuse or share needles. Reuse dulls the needle, raises infection risk, and contributes to lumps. Sharing risks bloodborne disease.
Never recap a needle with two hands. If you must recap, use the one-handed "scoop" method, but it is safer to drop it straight into the sharps container.

Safe Sharps Disposal

Used needles are biohazardous and cannot go in household trash, recycling, or down the toilet. The FDA's guidance is specific (FDA: Best Way to Get Rid of Used Needles):

Drop the needle into an FDA-cleared sharps container right after use.
If you do not have one, a heavy-duty plastic container with a screw-on, puncture-resistant lid (like a laundry detergent jug) can serve as a backup.
Seal it when it is about three-quarters full, never overfill it.
Dispose of full containers through your local program. Options vary by area and include drop-off sites, mail-back programs, and household hazardous waste collection.

The FDA's "do's and don'ts" sheet is worth a one-time read because disposal rules are local (FDA: DOs and DON'Ts of Proper Sharps Disposal).

Needle Selection: Length, Gauge, and Angle

The insulin-injection research is the best evidence base we have for subcutaneous technique, and its lessons transfer directly.

The FITTER (Forum for Injection Technique and Therapy: Expert Recommendations) panel of diabetes experts concluded that the shortest needles, the 4 mm pen needle and 6 mm syringe needle, are safe and effective and should be first choice for most people, because they reduce the chance of accidentally injecting into muscle (Frid et al., Mayo Clinic Proceedings 2016). The same recommendations stress avoiding intramuscular delivery for drugs meant to go subcutaneous, since it speeds and distorts absorption.

Translating that to peptides:

Goal	Practical choice
Least painful subQ shot	Thinner needle (31G), shortest length that reaches fat
Lean person, low body fat	Pinch skin, consider 45° angle to stay out of muscle
Accurate small doses	Smaller-barrel insulin syringe (0.3 mL) reads units more clearly
Avoiding lumps	Rotate sites, use a fresh needle each time

Bigger and longer is not better here. For subcutaneous peptides, short and thin does the job with less pain and less risk of going too deep.

Storage and Reconstitution Reminders

Injection safety starts before the needle. Lyophilized peptide has to be reconstituted with bacteriostatic water (sterile water with 0.9% benzyl alcohol, which limits bacterial growth across repeated vial entries). After reconstitution, peptides are generally kept refrigerated at about 2–8°C and used within a limited window, often cited around 28 days, depending on the compound and vendor instructions. Add the wrong volume of water and every dose you draw will be wrong, so get the math right first. Our peptide reconstitution guide covers the mixing and dosing arithmetic in detail.

The Honest Evidence Picture

Here is where sober beats hype. The technique for subcutaneous injection is well-established, backed by decades of insulin and biologic-drug research. Those parts of this guide rest on solid ground.

What is not solid is the human safety and efficacy of most of the peptides people inject this way. BPC-157, TB-500, and similar compounds have promising animal data and a lot of online testimony, but few or no rigorous human trials, and they are not FDA-approved. Knowing how to inject cleanly does not make an unstudied substance safe. The cleanest needle in the world still delivers an unknown into your body.

The regulatory backdrop matters. The FDA has flagged certain peptide bulk substances as potentially presenting significant safety risks for compounding (FDA: Certain Bulk Drug Substances That May Present Significant Safety Risks). In April 2026 the FDA removed several peptides, including BPC-157 and TB-500, from its Category 2 "significant safety risks" list, but did not approve them or place them on the 503A bulk substances list, leaving them in a gray zone pending an advisory committee review (Orrick analysis, April 2026; FDA PCAC meeting, July 2026). Removal from a risk list is not the same as a finding of safety.

Bottom line on evidence: injection mechanics, strong. Human safety data for most research peptides, weak to absent.

Who This Is For (and Who Should Not Self-Inject)

Self-injection technique is relevant to people prescribed an FDA-approved injectable peptide who want to do it correctly, and to those weighing the risks of research compounds with eyes open.

You should not be self-injecting if:

You have a bleeding disorder or take blood thinners without clearing it with a clinician.
You cannot maintain a clean technique or safely handle sharps.
You are dealing with an unknown-purity vial from an unverified source.
You are pregnant, breastfeeding, or managing a serious medical condition without medical oversight.

The safest path for anyone serious about peptides is to work with a licensed clinician who can supervise dosing, source pharmaceutical-grade product, and catch problems early. Our guides on how to start peptide therapy and the peptide therapy safety checklist lay out how to vet a provider and a product.

Frequently Asked Questions

Do I need to aspirate (pull back to check for blood) before a subcutaneous injection?

No. Aspiration is not recommended for routine subcutaneous injections. The fat layer has few large blood vessels, and pulling back wastes time and can move the needle. Aspiration is sometimes still discussed for specific intramuscular injections, but for the shallow subQ shots used with most peptides, you simply insert and inject.

What angle should I inject at, 45 or 90 degrees?

It depends on how much skin you can pinch. If you can grab about two inches of skin and fat, 90 degrees is fine. If you can only pinch about an inch, use 45 degrees so the dose lands in fat instead of muscle. Leaner people and those using slightly longer needles benefit most from the 45-degree angle and a firm skin pinch.

How do I keep from getting lumps at injection sites?

Rotate. Move each injection at least one to two inches from the last, cycle through different body areas, and never use the same spot more than once or twice a month. Also use a fresh needle every time. Repeated injections in one place and needle reuse are the two biggest causes of lipohypertrophy, the rubbery fat lumps that distort how a drug absorbs.

Can I reuse an insulin syringe to save money?

No. Reusing a needle dulls the tip, which makes the next injection more painful and more traumatic to tissue, raises infection risk, and contributes to lumps. Syringes are single-use. Drop each one in your sharps container right after use and never share with anyone.

How do I throw away used needles safely?

Place each used needle in an FDA-cleared sharps container immediately, or a heavy-duty plastic container with a tight, puncture-resistant lid as a backup. Seal it when it is about three-quarters full. Never put loose needles in household trash, recycling, or the toilet. Dispose of full containers through your local sharps program, which may include drop-off sites or mail-back options.

The Bottom Line

Subcutaneous injection technique is straightforward and well-supported by evidence: clean hands, clean site, pinch, short fine needle, rotate, and dispose of sharps safely. The mechanics are not where the real risk lives. The risk lives in what you are injecting, because most research peptides have little to no human safety data and are not FDA-approved. Master the technique, but do not let a clean needle talk you into trusting an unstudied compound, and bring a licensed clinician into the loop.

This article is for educational purposes only and is not medical advice. Most peptides discussed are not FDA-approved for human use. Talk to a licensed healthcare provider before starting or self-administering any injectable substance.